4893 items matching your search terms.

Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors

Nowak, AK Robinson, BW Lake, RA

Use of the EORTC QLQ-C30 and LC13 in a study of combination chemotherapy for pleural malignant mesothelioma: feasibility, validity and baseline HRQL

Nowak, A Stockler, M Byrne, M

Adjuvant chemotherapy for early colon cancer: what do investigators think makes it worthwhile?

Nowak, A Stockler, M Duric, V Heritier, S Beale, P

Taxane containing regimens for the adjuvant treatment of early breast cancer

Nowak, A Stockler, M Wilcken, N Ghersi, D

Different outcomes in patients with ST-elevation myocardial infarction among countries with different gross national income

Orlandini, A; Pieper, K; Armstrong, P; Van de Werf, F; White, H; Simes, J; Lee, K; Paolasso, E

Continuation of an adjuvant therapy trial in the light of new evidence: revised design of the European Study Group for Pancreatic Cancer 3 trial (ESPAC-3)

Padbury, R; Goldstein, D; Knight, E; Dhillon, H; Tebbutt, N; Yip, S; Simes, J

Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials

PCAT Collaboration,
AMERICAN HEART JOURNAL, 2003     DOI:10.1067/mhj.2003.40

Clinical trials research in the new millennium: the International Clinical Trials Symposium, Sydney, 21–23 October 2002

Pike, R; Keech, AC; Simes, RJ

Clinical trials research in the new millennium: The International Clinical Trials Symposium, Sydney, 21-23 October 2002

Pike, R. Keech, A. C. Simes, R. J.

Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease

PROGRESS Collaborative Group,
EUROPEAN HEART JOURNAL, 2003     DOI:10.1016/s0195-668x(02)00804-7

Mesothelin-family proteins and diagnosis of mesothelioma

Robinson, BW Creaney, J Lake, R Nowak, A Musk, AW de Klerk, N Winzell, P Hellstrom, KE Hellstrom, I

Issues in the globalization of clinical trials. Lessons from the HERO-2 trial

Simes, J.

Continuing FIELD with revised outcomes

Simes, J

Clinical effectiveness versus cost-effectiveness. Clinical Trials Symposium

Simes, J

Practical issues in large-scale long-term trials

Simes, J